echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Up to 91.23 per cent reduction: Abbott, China Resources, Fish Leap...

    Up to 91.23 per cent reduction: Abbott, China Resources, Fish Leap...

    • Last Update: 2021-01-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Pharmaceutical network January 8th, two categories of consumables, the highest price reduction of 91% January 5, according to people's network news, recently Nanjing Medical Supplies International Expo Museum in Nanjing medical supplies on a disposable abdominal puncture device, disposable blood glucose test paper two types of medical supplies to start with volume procurement negotiations.
    negotiations continued from 2:00 pm to 7:00 pm, the average decline of the two types of medical supplies 67.42 percent, the highest decline of 91.23 percent, the lowest decline of 41 percent, the largest decline in a single group of abdominal puncturers, a decrease of 90.16 percent, the lowest decline of a single group of single-hole multi-channel group 41.26 percent.
    At the same time, Nanjing Municipal Health Insurance Bureau issued a "one-time abdominal puncture device and other parts of the medical supplies centralized belt procurement of the results of the proposed selection" shows that the proposed enterprises including Abbott, China Resources, Fish Leap Medical and other armed enterprises.
    According to limu information consulting industry reports, the current market more mainstream puncture devices are divided into disposable punctures and repetitive puncture devices, as endoscope minimally invasive surgery in the clinical department more and more popular, disposable puncture neutrinos minimally invasive surgery will gradually increase the proportion of use.
    china Medical Device Industry Association research data show that by 2020, the market size of disposable puncturers is expected to reach 9.636 billion yuan.
    For the blood sugar monitoring market, China Industry Information Network shows that the current hospital market because of the performance requirements of blood glucose meters and price sensitivity is lower than the retail market, foreign brands Roche, Johnson and Johnson accounted for the vast majority of the market, foreign brands market share of about 90%.
    2, not to low-cost hero according to the People's Network news, this negotiation does not to low-cost hero.
    Negotiations, the first negotiating variety is a one-time blood sugar test paper, business representatives sit down, the head of the negotiation team to the representative after a simple inquiry to ask the enterprise representative for the first round of quotations, business representatives in front of the draft paper and calculator, the reduction needs to be accurate to the bottom 4 places.
    reported that the price negotiations in Nanjing and the industry's much-discussed "soul negotiations" do not seem to be the same.
    can you go down again? Another drop? "Such words did not appear in the negotiating room.
    to this, Nanjing Municipal Health Insurance Bureau, the relevant person in charge said that the centralized procurement price negotiations are conducted under strict rules, there is no "bargaining" noise, but in the rules of the game.
    understood that the bidding negotiation rules are not the lowest price as the standard, but the establishment of a series of rules model, so that the negotiations have a game but not into a "vicious killing."
    Auction negotiation rules set the reference reduction and the conditions for termination of negotiations, Nanjing City Health Insurance Bureau said that the purpose is to select the best products and optimize the price, rather than choose low-cost products, hope that the first offer of enterprises to come up with the greatest sincerity, but also to avoid multiple quotations after killing the red eye leading to disorderly state affecting the clinic.
    the market accounted for a large number of enterprises did not have a winning bid, will it affect the clinical? In this regard, the rules put forward with the volume of procurement accounted for 70% of the total procurement volume, and 30% of the market left to the enterprises that did not bid, that is, even if not the winning bid will not have much impact on the clinic.
    if there is a problem with the winning product? In this regard, The Nanjing Municipal Health Insurance Bureau has established a "tracking mechanism" for winning products, once the problem will be timely adjustment of the band volume quota, if necessary, will cancel its volume procurement qualifications, and the groups of non-winning enterprises the largest price reduction, for this centralized procurement replenishment enterprises.
    3, Nanjing many times supplies cut prices January 5, Nanjing City Health Insurance Bureau issued "on 8.16 general medical supplies concentrated belt product continued procurement results of the announcement", the continuation of the procurement of selected products to be implemented on February 1, 2021.
    involving BD, Vigo, Belang, Sanxin and other equipment enterprises precision infusion, closed vein retention needles, infusion port, pre-charged catheter flushing machine and other medical supplies (the end of the list).
    , according to the Nanjing Municipal Health Insurance Bureau, on August 16, 2019, the Nanjing, Taizhou and Huai'an three-city alliance began the first negotiations on the amount of supplies.
    specifically related to implantable drug-giving devices (infusion port), pre-charged catheter flushing, precision infusion, closed lien needles and other 4 categories of 14 product regulation supplies, the final maximum price reduction of 80.39 percent, the lowest price reduction of 51.67 percent, the average decline of 72.61 percent in the three cities.
    On September 26, 2019, representatives of the hospital procurement alliance in Nanjing and Huai'an were officially invited to negotiate with the first production and supply company, prompting a one-time price reduction of more than 200 supplies at the same time, Xinhua Reported.
    According to the Nanjing Municipal Health Insurance Bureau, on October 30, 2019, the Nanjing Alliance completed the third round of supplies negotiations, the highest price reduction of 83.86 percent, in addition to the afternoon of the negotiations, the Nanjing Alliance and an arms company on all products for the overall negotiations, the overall decline of 30%.
    2020, the Nanjing Medical Security Bureau organized the third round of negotiations on the lowest-priced products, according to the Xiangxiang Morning Post.
    The negotiations, attended by 271 enterprises, confirmed the prices of 1002 general consumables and inspection reagent products, including injection punctures, medical polymers, surgical and anaesthetic supplies and other 15 categories of low-value consumables.
    the biggest drop was in ablation electrodes, which fell 80.2% from 650 yuan to 128.8 yuan.
    the overall decline of 20.31 percent, it is estimated that the annual savings after the price reduction of 91.3474 million yuan.
    reported that, previously, the Nanjing Municipal Health Insurance Bureau has organized two Nanjing area medical supplies lowest price products negotiations, involving 3,352 products, an average decline of 20.35 percent, has been saved 31.6 million yuan.
    Nanjing Municipal Health Insurance Bureau said that on November 5, 2020, the first round of high-value supplies national collection officially opened.
    National follow the pace of the State Health Insurance Bureau, to carry out the lowest price product negotiations, is the key to comprehensively deepen the reform of centralized procurement in the field of medicine, medical supplies management should not only give high-value supplies "clean heat to fire", but also to the general consumption reagents "chemical network", so as to achieve full coverage of governance, no blind spots.
    accessories:
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.